Publikationen

Heimrich, K.G.*, Schönenberg, A.*, Mendorf, S., Moussaoui, J., Prell, T. (2024). An examination of anxiety and its influence on health-related quality of life in Parkinson’s disease using the geriatric anxiety scale. BMC Geriatr 24, 298. doi.org/10.1186/s12877-024-04911-8

Schönenberg, A., Heimrich, K.G. & Prell, T. (2024). Impact of depressive symptoms on medication adherence in older adults with chronic neurological diseases. BMC Psychiatry 24, 131. doi.org/10.1186/s12888-024-05585-7

Mendorf, S., Heimrich, K. G., Mühlhammer, H. M., Prell, T. & Schönenberg, A. (2024). Trajectories of quality of life in people with diabetes mellitus: results from the survey of health, ageing and retirement in Europe. Frontiers in Psychology 14, https://doi.org/10.3389/fpsyg.2023.1301530 

Brückner, R.M., Schönenberg, A., Wientzek, R., Schreiber, M., Prell, T. (2024). Exploring factors associated with self-rated health in individuals with diabetes and its impact on quality of life: Evidence from the Survey of Health, Ageing, and Retirement in Europe. Journal of Diabetes. 1-14. https://doi.org/10.1111/1753-0407.13522 

Heimrich, K.G., Schönenberg, A., Prell, T. (2023). Social deprivation and exclusion in Parkinson’s disease: a cross-sectional and longitudinal study. BMJ Open ;13:e074618. https://doi.org/10.1136/bmjopen-2023-074618 

Wientzek, R., Brückner, R. M., Schönenberg, A. & Prell, T. (2023). Instruments for measuring self-management and self-care in geriatric patients – a scoping review. Frontiers in Public Health 11, https://doi.org/10.3389/fpubh.2023.1284350 

Prell, T., Wientzek, R. & Schönenberg, A. (2023). Self-management of geriatric syndromes - an observational study. BMC Geriatr 23, 731. doi.org/10.1186/s12877-023-04442-8

Pürner, D. (...), Prell. T, (...) et al. (2023). Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinsons Disease. Neurology.  https://doi.org/10.1212/WNL.0000000000207858  

Mendorf, S., Teschner, U., Lehmann, T., Prell, T., Mühlhammer, H.M. (2023). Tailored interventions to improve adherence to medication in elderly patients with Parkinson’s disease: a study protocol for a randomized controlled trial (AdhCare). Trials 24, 668. https://doi.org/10.1186/s13063-023-07663-9 

Prell, T., Schönenberg, A., Heimrich, K.G. (2023). The Impact of Loneliness on Quality of Life in People with Parkinson's Disease: Results from the Survey of Health, Ageing and Retirement in Europe (SHARE). Frontiers in Medicine, 10, https://doi.org/10.3389/fmed.2023.1183289    

Mendorf, S., Schönenberg, A., Heimrich, K. G. & Prell, T. (2023). Prospective associations between hand grip strength and subsequent depressive symptoms in men and women aged 50 years and older: insights from the Survey of Health, Aging, and Retirement in Europe. Frontiers in Medicine 10, https://doi.org/10.3389/fmed.2023.1260371  

Heimrich KG, Mendorf S, Schönenberg A, Santos-García D, Mir P, COPPADIS Study Group, Prell T. (2023). Depressive Symptoms and Their Impact on Quality of Life in Parkinson’s Disease: An Exploratory Network Analysis Approach. Journal of Clinical Medicine. 12(14):4616. https://doi.org/10.3390/jcm12144616  

Schönenberg, A., Santos García, D., Mir, P., Wu, J.J., Heimrich, K.G., Mühlhammer, H.M., Prell, T. (2023). Using network analysis to explore the validity and influential items of the Parkinson’s Disease Questionnaire-39. Sci Rep 13, 7221  https://doi.org/10.1038/s41598-023-34412-4 

Prell, T., Stegmann, S. & Schönenberg, A. (2023). Social exclusion in people with diabetes: cross-sectional and longitudinal results from the German Ageing Survey (DEAS). Sci Rep 13, 7113 https://doi.org/10.1038/s41598-023-33884-8 

Heimrich, K.G.; Schönenberg, A.; Santos-García, D.; Mir, P.; COPPADIS Study Group; Prell, T. (2023). The Impact of Nonmotor Symptoms on Health-Related Quality of Life in Parkinson’s Disease: A Network Analysis Approach. J. Clin. Med.12, 2573. https://doi.org/10.3390/jcm12072573 

Heimrich, K.G., Schönenberg A., Mühlhammer, H.M., Mendorf, S., Santos-Garcia, D., Prell, T. (2023). Longitudinal Analysis of the Non-Motor Symptoms Scale in Parkinson's Disease (NMSS): An Exploratory Network Analysis Approach, Frontiers in Neurology 14, https://doi.org/10.3389/fneur.2023.972210

Mühlhammer, H.M., Schönenberg, A., Lehmann, T., Prell, T. (2023). Using a generic quality of life measure to determine adherence thresholds – a cross-sectional study on older adults with neurological disorders in Germany, BMJ Open, 13:e067326. https://doi.org/10.1136/bmjopen-2022-067326

Uhlig, M., Prell, T. (2023). Gait Characteristics Associated with Fear of Falling in Hospitalized People with Parkinson’s Disease. Sensors. 23(3):1111. https://doi.org/10.3390/s23031111

Prell, T., & Axer, H. (2022). Avoidance Behavior in Patients with Chronic Dizziness: A Prospective Observational Study. Journal of clinical medicine, 11(24), 7473. https://doi.org/10.3390/jcm11247473

Prell, T., Schönenberg, A., Mendorf, S., Mühlhammer, H. M., Grosskreutz, J., & Teschner, U. (2022). Data on medication adherence in adults with neurological disorders: The NeuroGerAd study. Scientific data, 9(1), 734. https://doi.org/10.1038/s41597-022-01847-9

Schönenberg, A., Mühlhammer, H. M., Lehmann, T., & Prell, T. (2022). Adherence to Medication in Neurogeriatric Patients: Insights from the NeuroGerAd Study. Journal of clinical medicine, 11(18), 5353. https://doi.org/10.3390/jcm11185353

Schönenberg, A., Teschner, U., Prell, T., & Mühlhammer, H. M. (2022). Validation and Psychometric Analysis of the German Translation of the Appraisal of Self-Care Agency Scale-Revised. Healthcare (Basel, Switzerland), 10(9), 1785. https://doi.org/10.3390/healthcare10091785

Dieckmann, N., Roediger, A., Prell, T., Schuster, S., Herdick, M., Mayer, T. E., Witte, O. W., Steinbach, R., & Grosskreutz, J. (2022). Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness. NeuroImage. Clinical, 36, 103162. https://doi.org/10.1016/j.nicl.2022.103162

Heimrich, K. G., & Prell, T. (2022). Data on the effect of Parkinson's disease multimodal complex treatment in a German University Hospital. Data in brief, 44, 108496. https://doi.org/10.1016/j.dib.2022.108496

Prell, T., Mendorf, S., & Axer, H. (2022). Tolerance to Dizziness Intensity Increases With Age in People With Chronic Dizziness. Frontiers in neurology, 13, 934627. https://doi.org/10.3389/fneur.2022.934627

Mendorf, S., Prell, T., & Schönenberg, A. (2022). Detecting Reasons for Nonadherence to Medication in Adults with Epilepsy: A Review of Self-Report Measures and Key Predictors. Journal of clinical medicine, 11(15), 4308. https://doi.org/10.3390/jcm11154308

Heimrich, K. G., Prell, T., & Schönenberg, A. (2022). What Determines That Older Adults Feel Younger Than They Are? Results From a Nationally Representative Study in Germany. Frontiers in medicine, 9, 901420. https://doi.org/10.3389/fmed.2022.901420

Scholz, K., Geritz, J., Kudelka, J., Rogalski, M., Niemann, K., Maetzler, C., Welzel, J., Drey, M., Prell, T., & Maetzler, W. (2022). Static Balance and Chair-Rise Performance in Neurogeriatric Patients: Promising Short Physical Performance Battery-Derived Predictors of Fear of Falling. Frontiers in medicine, 9, 904364. https://doi.org/10.3389/fmed.2022.904364

Prell, T., Liebermann, J. D., Mendorf, S., & Zipprich, H. M. (2022). Data on pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study. Data in brief, 42, 108288. https://doi.org/10.1016/j.dib.2022.108288

Schönenberg, A., Zipprich, H. M., Teschner, U., & Prell, T. (2022). Impact of Depression, Resilience, and Locus of Control on Adjustment of Health-Related Expectations in Aging Individuals With Chronic Illness. Frontiers in psychology, 13, 867785. https://doi.org/10.3389/fpsyg.2022.867785

Prell, T., Franke, G. H., Jagla-Franke, M., & Schönenberg, A. (2022). Identifying Patterns of Self-Reported Nonadherence Using Network Analysis in a Mixed German Cohort. Patient preference and adherence, 16, 1153–1162. https://doi.org/10.2147/PPA.S362464

Prell, T., Finn, S., Zipprich, H. M., & Axer, H. (2022). What Predicts Improvement of Dizziness after Multimodal and Interdisciplinary Day Care Treatment? Journal of clinical medicine, 11(7), 2005. https://doi.org/10.3390/jcm11072005

Schönenberg, A., & Prell, T. (2022). Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment. PloS one, 17(4), e0266140. https://doi.org/10.1371/journal.pone.0266140

Prell, T., Uhlig, M., Derlien, S., Maetzler, W., & Zipprich, H. M. (2022). Fear of Falling Does Not Influence Dual-Task Gait Costs in People with Parkinson's Disease: A Cross-Sectional Study. Sensors (Basel, Switzerland), 22(5), 2029. https://doi.org/10.3390/s22052029

Prell, T., Finn, S., & Axer, H. (2022). How Healthcare Utilization Due to Dizziness and Vertigo Differs Between Older and Younger Adults. Frontiers in medicine, 9, 852187. https://doi.org/10.3389/fmed.2022.852187

Schwarzkopf, A., Schönenberg, A., & Prell, T. (2022). Patterns and Predictors of Medication Change after Discharge from Hospital: An Observational Study in Older Adults with Neurological Disorders. Journal of clinical medicine, 11(3), 563. https://doi.org/10.3390/jcm11030563

Prell, T., Wassermann, A., Zipprich, H. M., Finn, S., & Axer, H. (2021). Impact of Common Dizziness Associated Symptoms on Dizziness Handicap in Older Adults. Frontiers in neurology, 12, 801499. https://doi.org/10.3389/fneur.2021.801499

Schönenberg, A., & Prell, T. (2021). Factors Influencing Self-Reported Medication Use in the Survey of Health Aging and Retirement in Europe (SHARE) Dataset. Healthcare, 9(12), 1752. https://doi.org/10.3390/healthcare9121752

Heimrich, K. G., & Prell, T. (2021). Short- and Long-Term Effect of Parkinson's Disease Multimodal Complex Treatment. Brain sciences, 11(11), 1460. https://doi.org/10.3390/brainsci11111460

Zipprich, H. M., Mendorf, S., Schönenberg, A., & Prell, T. (2021). The impact of poor medication knowledge on health-related quality of life in people with Parkinson's disease: a mediation analysis. Quality of life research, 31(5), 1473–1482. https://doi.org/10.1007/s11136-021-03024-8

Prell, T., Vlad, B., Gaur, N., Stubendorff, B., & Grosskreutz, J. (2021). Blood-Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis. Frontiers in neuroscience, 15, 656456. https://doi.org/10.3389/fnins.2021.656456

Prell, T., Liebermann, J. D., Mendorf, S., Lehmann, T., & Zipprich, H. M. (2021). Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study. PloS one, 16(11), e0257966. https://doi.org/10.1371/journal.pone.0257966

Schönenberg, A., Teschner, U., & Prell, T. (2021). Expectations and behaviour of older adults with neurological disorders regarding general practitioner consultations: an observational study. BMC geriatrics, 21(1), 512. https://doi.org/10.1186/s12877-021-02469-3

Gerland, H. E., & Prell, T. (2021). Association Between the Health Locus of Control and Medication Adherence: An Observational, Cross-Sectional Study in Primary Care. Frontiers in medicine, 8, 705202. https://doi.org/10.3389/fmed.2021.705202

Heimrich, K. G., Lehmann, T., Schlattmann, P., & Prell, T. (2021). Heart Rate Variability Analyses in Parkinson's Disease: A Systematic Review and Meta-Analysis. Brain sciences, 11(8), 959. https://doi.org/10.3390/brainsci11080959

Franke, G. H., Nentzl, J., Jagla-Franke, M., & Prell, T. (2021). Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study. Patient preference and adherence, 15, 1439–1449. https://doi.org/10.2147/PPA.S311946

Gaur, N., Huss, E., Prell, T., Steinbach, R., Guerra, J., Srivastava, A., Witte, O. W., & Grosskreutz, J. (2021). Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study. Frontiers in neurology, 12, 629332. https://doi.org/10.3389/fneur.2021.629332

Zipprich, H. M., & Prell, T. (2021). Difficulties in reporting purpose and dosage of prescribed medications are associated with poor cognition and depression. PloS one, 16(5), e0251374. https://doi.org/10.1371/journal.pone.0251374

Steinbach, R., Prell, T., Gaur, N., Roediger, A., Gaser, C., Mayer, T. E., Witte, O. W., & Grosskreutz, J. (2021). Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis. NeuroImage. Clinical, 30, 102674. https://doi.org/10.1016/j.nicl.2021.102674

Schönenberg, A., Zipprich, H. M., Teschner, U., Grosskreutz, J., Witte, O. W., & Prell, T. (2021). Impact of subthreshold depression on health-related quality of life in patients with Parkinson's disease based on cognitive status. Health and quality of life outcomes, 19(1), 107. https://doi.org/10.1186/s12955-021-01753-5

Zipprich, H. M., Mendorf, S., Lehmann, T., & Prell, T. (2021). Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson's Disease. Brain sciences, 11(2), 273. https://doi.org/10.3390/brainsci11020273

Zipprich, H. M., Schönenberg, A., Teschner, U., & Prell, T. (2021). Changes of perceptions and behaviours during the phases of COVID-19 pandemic in German elderly people with neurological disorders: an observational study using telephone interviews. BMJ open, 11(1), e045780. https://doi.org/10.1136/bmjopen-2020-045780

Mendorf, S., Witte, O. W., Zipprich, H., & Prell, T. (2020). Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease. Frontiers in neurology, 11, 551696. https://doi.org/10.3389/fneur.2020.551696

Steinbach, R., Gaur, N., Roediger, A., Mayer, T. E., Witte, O. W., Prell, T., & Grosskreutz, J. (2021). Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Human brain mapping, 42(3), 737–752. https://doi.org/10.1002/hbm.25258

2020:

Steinbach, R., Prell, T., Gaur, N., Stubendorff, B., Roediger, A., Ilse, B., Witte, O. W., & Grosskreutz, J. (2020). Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model. Journal of clinical medicine, 9(9), 2873. https://doi.org/10.3390/jcm9092873

Prell, T., Grosskreutz, J., & Pooled Resource Open-Access ALS Clinical Trials Consortium (2020). Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials. PloS one, 15(8), e0237175. https://doi.org/10.1371/journal.pone.0237175

Prell, T., Siebecker, F., Lorrain, M., Tönges, L., Warnecke, T., Klucken, J., Wellach, I., Buhmann, C., Wolz, M., Lorenzl, S., Herbst, H., Eggers, C., & Mai, T. (2020). Specialized Staff for the Care of People with Parkinson's Disease in Germany: An Overview. Journal of clinical medicine, 9(8), 2581. https://doi.org/10.3390/jcm9082581

Feldmann, F., Zipprich, H. M., Witte, O. W., & Prell, T. (2020). Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease. Parkinson's disease, 2020, 4315489. https://doi.org/10.1155/2020/4315489

Liebermann, J. D., Witte, O. W., & Prell, T. (2020). Association between different coping styles and health-related quality of life in people with Parkinson's disease: a cross-sectional study. BMJ open, 10(7), e036870. https://doi.org/10.1136/bmjopen-2020-036870

Zipprich, H. M., Teschner, U., Witte, O. W., Schönenberg, A., & Prell, T. (2020). Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany. Journal of clinical medicine, 9(6), 1643. https://doi.org/10.3390/jcm9061643

Jacobs, A. H., Emmert, K., Baron, R., Bartsch, T., Bauer, J., Becker, C., Berg, D., Bergmann, P., Boetzel, K., Bollheimer, C., Deuschl, G., Djukic, M., Drey, M., Durwen, H., Ebersbach, G., Elshehabi, M., Geritz, J., Gisinger, C., Guennewig, T., Hauptmann, B., Prell, T.,… Maetzler, W. (2020). Neurogeriatrics-a vision for improved care and research for geriatric patients with predominating neurological disabilities. Neurogeriatrie – eine Vision für die verbesserte Versorgung und Forschung für geriatrische Patienten mit führend neurologischen Erkrankungen. Zeitschrift fur Gerontologie und Geriatrie, 53(4), 340–346. https://doi.org/10.1007/s00391-020-01734-1

Prell, T., Teschner, U., Witte, O. W., & Kunze, A. (2020). Current and Desired Quality of Life in People with Parkinson's Disease: the Calman Gap Increases with Depression. Journal of clinical medicine, 9(5), 1496. https://doi.org/10.3390/jcm9051496

Prell, T., Siebecker, F., Lorrain, M., Eggers, C., Lorenzl, S., Klucken, J., Warnecke, T., Buhmann, C., Tönges, L., Ehret, R., Wellach, I., & Wolz, M. (2020). Recommendations for Standards of Network Care for Patients with Parkinson's Disease in Germany. Journal of clinical medicine, 9(5), 1455. https://doi.org/10.3390/jcm9051455

Schijven, D., Stevelink, R., McCormack, M., van Rheenen, W., Luykx, J. J., Koeleman, B. P. C., Veldink, J. H., Project MinE ALS GWAS Consortium, & International League Against Epilepsy Consortium on Complex Epilepsies (2020). Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy. Neurobiology of aging, 92, 153.e1–153.e5. https://doi.org/10.1016/j.neurobiolaging.2020.04.011

Gruber, M. T., Witte, O. W., Grosskreutz, J., & Prell, T. (2020). Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study. PloS one, 15(5), e0232764. https://doi.org/10.1371/journal.pone.0232764

Prell, T., Gaur, N., Steinbach, R., Witte, O. W., & Grosskreutz, J. (2020). Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data. Health and quality of life outcomes, 18(1), 117. https://doi.org/10.1186/s12955-020-01372-6

Reichmann, H., Lees, A., Rocha, J. F., Magalhães, D., Soares-da-Silva, P., & OPTIPARK investigators (2020). Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study. Translational neurodegeneration, 9(1), 9. https://doi.org/10.1186/s40035-020-00187-1

Mendorf, S., Witte, O. W., Grosskreutz, J., Zipprich, H. M., & Prell, T. (2020). What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease?. Frontiers in medicine, 7, 103. https://doi.org/10.3389/fmed.2020.00103

Eggers, C., Wolz, M., Warnecke, T., Prell, T., & Tönges, L. (2020). Parkinson-Netzwerke in Deutschland: Zukunft oder Utopie? [Parkinson Networks in Germany: Future or Utopia?]. Fortschritte der Neurologie-Psychiatrie, 88(9), 586–589. https://doi.org/10.1055/a-1113-7751

Zipprich, H. M., Arends, M. C., Schumacher, U., Bahr, V., Scherag, A., Kwetkat, A., Wedding, U., Brunkhorst, F. M., Witte, O. W., Prell, T., & Redecker, C. (2020). Outcome of Older Patients with Acute Neuropsychological Symptoms Not Fulfilling Criteria of Delirium. Journal of the American Geriatrics Society, 68(7), 1469–1475. https://doi.org/10.1111/jgs.16422

Prell, T., Schaller, D., Perner, C., Witte, O. W., & Grosskreutz, J. (2020). Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life. Parkinson's disease, 2020, 2958635. https://doi.org/10.1155/2020/2958635

Steinbach, R., Batyrbekova, M., Gaur, N., Voss, A., Stubendorff, B., Mayer, T. E., Gaser, C., Witte, O. W., Prell, T., & Grosskreutz, J. (2020). Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. NeuroImage. Clinical, 25, 102094. https://doi.org/10.1016/j.nicl.2019.102094

Gottschling, J., Dörendahl, J., Prell, T., Karbach, J., Bunz, M., Kindermann, I., Moussaoui, J., Spinath, F. M., Wedegärtner, S., Witte, O. W., Greiff, S., & Segal, D. L. (2020). Measuring Anxiety in Older Adults: Development, Diagnostic Accuracy, and Preliminary Validation of a Short-Form of the German Geriatric Anxiety Scale (GAS-G-SF). Journal of personality assessment, 102(2), 196–204. https://doi.org/10.1080/00223891.2019.1677679

Prell, T., Witte, O. W., Gunkel, A., & Grosskreutz, J. (2020). Cognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosis. Aging & mental health, 24(12), 1963–1967. https://doi.org/10.1080/13607863.2019.1642296

Prell, T., Steinbach, R., Witte, O. W., & Grosskreutz, J. (2019). Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis. eNeurologicalSci, 16, 100198. https://doi.org/10.1016/j.ensci.2019.100198

Heimrich, K. G., Jacob, V. Y. P., Schaller, D., Stallmach, A., Witte, O. W., & Prell, T. (2019). Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells. NPJ Parkinson's disease, 5, 15. https://doi.org/10.1038/s41531-019-0087-3

Prell, T., Grosskreutz, J., Mendorf, S., Witte, O. W., & Kunze, A. (2019). Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS). Data in brief, 23, 103855. https://doi.org/10.1016/j.dib.2019.103855

Prell T. (2019). Adherence to medication in neurogeriatric patients: an observational cross-sectional study. BMC public health, 19(1), 1012. https://doi.org/10.1186/s12889-019-7353-5

Warnecke, T., Dziewas, R., Wirth, R., Bauer, J. M., & Prell, T. (2019). Dysphagia from a neurogeriatric point of view : Pathogenesis, diagnosis and management. Dysphagie aus neurogeriatrischer Sicht : Pathogenese, Diagnostik und Management. Zeitschrift fur Gerontologie und Geriatrie, 52(4), 330–335. https://doi.org/10.1007/s00391-019-01563-x

Perner, C., Perner, F., Gaur, N., Zimmermann, S., Witte, O. W., Heidel, F. H., Grosskreutz, J., & Prell, T. (2019). Plasma VCAM1 levels correlate with disease severity in Parkinson's disease. Journal of neuroinflammation, 16(1), 94. https://doi.org/10.1186/s12974-019-1482-8

Brodoehl, S., Wagner, F., Prell, T., Klingner, C., Witte, O. W., & Günther, A. (2019). Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment. NeuroImage. Clinical, 22, 101792. https://doi.org/10.1016/j.nicl.2019.101792

Prell, T., Witte, O. W., & Grosskreutz, J. (2019). Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease. Frontiers in neurology, 10, 195. https://doi.org/10.3389/fneur.2019.00195

Prell, T., Grosskreutz, J., Mendorf, S., Franke, G. H., Witte, O. W., & Kunze, A. (2019). Clusters of non-adherence to medication in neurological patients. Research in social & administrative pharmacy, 15(12), 1419–1424. https://doi.org/10.1016/j.sapharm.2019.01.001

Prell, T., Stubendorff, B., Le, T. T., Gaur, N., Tadić, V., Rödiger, A., Witte, O. W., & Grosskreutz, J. (2019). Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging. Frontiers in aging neuroscience, 11, 5. https://doi.org/10.3389/fnagi.2019.00005

Prell, T., Schaller, D., Perner, C., Franke, G. H., Witte, O. W., Kunze, A., & Grosskreutz, J. (2019). Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson's disease. Patient preference and adherence, 13, 151–155. https://doi.org/10.2147/PPA.S186732

Prell, T., Dirks, M., Arvanitis, D., Braun, D., Peschel, T., Worthmann, H., Schuppner, R., Raab, P., Grosskreutz, J., & Weissenborn, K. (2019). Cerebral patterns of neuropsychological disturbances in hepatitis C patients. Journal of neurovirology, 25(2), 229–238. https://doi.org/10.1007/s13365-018-0709-2

Prell, T., Gaur, N., Stubendorff, B., Rödiger, A., Witte, O. W., & Grosskreutz, J. (2019). Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis. Journal of the neurological sciences, 397, 92–95. https://doi.org/10.1016/j.jns.2018.12.035

Sengupta, S., Le, T. T., Adam, A., Tadić, V., Stubendorff, B., Keiner, S., Kloss, L., Prell, T., Witte, O. W., & Grosskreutz, J. (2019). Interferon-γ Receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice. The European journal of neuroscience, 49(1), 62–78. https://doi.org/10.1111/ejn.14276

Fedtke, N., Witte, O. W., & Prell, T. (2018). Ultrasonography of the Vagus Nerve in Parkinson's Disease. Frontiers in neurology, 9, 525. https://doi.org/10.3389/fneur.2018.00525

Prell, T., & Perner, C. (2018). Disease Specific Aspects of Malnutrition in Neurogeriatric Patients. Frontiers in aging neuroscience, 10, 80. https://doi.org/10.3389/fnagi.2018.00080

Prell T. (2018). Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson's Disease. Frontiers in neurology, 9, 138. https://doi.org/10.3389/fneur.2018.00138

Perner, C., Perner, F., Stubendorff, B., Förster, M., Witte, O. W., Heidel, F. H., Prell, T., & Grosskreutz, J. (2018). Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients. Journal of neuroinflammation, 15(1), 99. https://doi.org/10.1186/s12974-018-1135-3

Tadić, V., Malci, A., Goldhammer, N., Stubendorff, B., Sengupta, S., Prell, T., Keiner, S., Liu, J., Guenther, M., Frahm, C., Witte, O. W., & Grosskreutz, J. (2017). Sigma 1 receptor activation modifies intracellular calcium exchange in the G93AhSOD1 ALS model. Neuroscience, 359, 105–118. https://doi.org/10.1016/j.neuroscience.2017.07.012

Poesen, K., De Schaepdryver, M., Stubendorff, B., Gille, B., Muckova, P., Wendler, S., Prell, T., Ringer, T. M., Rhode, H., Stevens, O., Claeys, K. G., Couwelier, G., D'Hondt, A., Lamaire, N., Tilkin, P., Van Reijen, D., Gourmaud, S., Fedtke, N., Heiling, B., Rumpel, M., … Van Damme, P. (2017). Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology, 88(24), 2302–2309. https://doi.org/10.1212/WNL.0000000000004029

Liu, J., Prell, T., Stubendorff, B., Keiner, S., Ringer, T., Gunkel, A., Tadic, V., Goldhammer, N., Malci, A., Witte, O. W., & Grosskreutz, J. (2016). Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis. Neuroscience letters, 630, 77–83. https://doi.org/10.1016/j.neulet.2016.07.039

Prell, T., Ringer, T. M., Wullenkord, K., Garrison, P., Gunkel, A., Stubendorff, B., Witte, O. W., & Grosskreutz, J. (2016). Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?. Journal of neurology, neurosurgery, and psychiatry, 87(9), 1022–1026. https://doi.org/10.1136/jnnp-2015-312185

Müller, H. P., Turner, M. R., Grosskreutz, J., Abrahams, S., Bede, P., Govind, V., Prudlo, J., Ludolph, A. C., Filippi, M., Kassubek, J., & Neuroimaging Society in ALS (NiSALS) DTI Study Group (2016). A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry, 87(6), 570–579. https://doi.org/10.1136/jnnp-2015-311952

Schmidt, V., Prell, T., Treschl, A., Klink, A., Hochhaus, A., & Sayer, H. G. (2016). Clinical Management of Posterior Reversible Encephalopathy Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series and Review of the Literature. Acta haematologica, 135(1), 1–10. https://doi.org/10.1159/000430489

Prell, T., Hartung, V., Tietz, F., Penzlin, S., Ilse, B., Schweser, F., Deistung, A., Bokemeyer, M., Reichenbach, J. R., Witte, O. W., & Grosskreutz, J. (2015). Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis. PloS one, 10(6), e0131114. https://doi.org/10.1371/journal.pone.0131114

Glahn, A., Prell, T., Grosskreutz, J., Peschel, T., & Müller-Vahl, K. R. (2015). Obsessive-compulsive disorder is a heterogeneous disorder: evidence from diffusion tensor imaging and magnetization transfer imaging. BMC psychiatry, 15, 135. https://doi.org/10.1186/s12888-015-0535-5

Fazekas, F., Enzinger, C., Schmidt, R., Grittner, U., Giese, A. K., Hennerici, M. G., Huber, R., Jungehulsing, G. J., Kaps, M., Kessler, C., Martus, P., Putaala, J., Ropele, S., Tanislav, C., Tatlisumak, T., Thijs, V., von Sarnowski, B., Norrving, B., Rolfs, A., & SIFAP 1 Investigators (2015). Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event. Stroke, 46(6), 1548–1553. https://doi.org/10.1161/STROKEAHA.114.008548

Hartung, V., Prell, T., Gaser, C., Turner, M. R., Tietz, F., Ilse, B., Bokemeyer, M., Witte, O. W., & Grosskreutz, J. (2014). Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis. PloS one, 9(8), e104894. https://doi.org/10.1371/journal.pone.0104894

Tadic, V., Prell, T., Lautenschlaeger, J., & Grosskreutz, J. (2014). The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Frontiers in cellular neuroscience, 8, 147. https://doi.org/10.3389/fncel.2014.00147

Prell, T., Schenk, A., Witte, O. W., Grosskreutz, J., & Günther, A. (2014). Transcranial brainstem sonography as a diagnostic tool for amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration, 15(3-4), 244–249. https://doi.org/10.3109/21678421.2014.881499

Müller-Vahl, K. R., Grosskreutz, J., Prell, T., Kaufmann, J., Bodammer, N., & Peschel, T. (2014). Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms. BMC neuroscience, 15, 6. https://doi.org/10.1186/1471-2202-15-6

Fazekas, F., Enzinger, C., Schmidt, R., Dichgans, M., Gaertner, B., Jungehulsing, G. J., Hennerici, M. G., Heuschmann, P., Holzhausen, M., Kaps, M., Kessler, C., Martus, P., Putaala, J., Ropele, S., Tanislav, C., Tatlisumak, T., Norrving, B., Rolfs, A., & sifap1 Investigators (2013). MRI in acute cerebral ischemia of the young: the Stroke in Young Fabry Patients (sifap1) Study. Neurology, 81(22), 1914–1921. https://doi.org/10.1212/01.wnl.0000436611.28210.ec

Prell, T., Peschel, T., Köhler, B., Bokemeyer, M. H., Dengler, R., Günther, A., & Grosskreutz, J. (2013). Structural brain abnormalities in cervical dystonia. BMC neuroscience, 14, 123. https://doi.org/10.1186/1471-2202-14-123

Prell, T., & Grosskreutz, J. (2013). The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration, 14(7-8), 507–515. https://doi.org/10.3109/21678421.2013.812661

Prell, T., Lautenschläger, J., & Grosskreutz, J. (2013). Calcium-dependent protein folding in amyotrophic lateral sclerosis. Cell calcium, 54(2), 132–143. https://doi.org/10.1016/j.ceca.2013.05.007

Lautenschläger, J., Prell, T., Ruhmer, J., Weidemann, L., Witte, O. W., & Grosskreutz, J. (2013). Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons. Experimental neurology, 247, 91–100. https://doi.org/10.1016/j.expneurol.2013.03.027

Prell, T., Peschel, T., Hartung, V., Kaufmann, J., Klauschies, R., Bodammer, N., Kollewe, K., Dengler, R., & Grosskreutz, J. (2013). Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis. Clinical neurology and neurosurgery, 115(8), 1281–1287. https://doi.org/10.1016/j.clineuro.2012.11.031

Keil, C., Prell, T., Peschel, T., Hartung, V., Dengler, R., & Grosskreutz, J. (2012). Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC neuroscience, 13, 141. https://doi.org/10.1186/1471-2202-13-141

Decker, M., Prell, T., Schelhorn-Neise, P., Küpper, H., Witte, O. W., & Grosskreutz, J. (2012). Specially designed palate prosthesis reconstitutes speech in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis, 13(6), 560–561. https://doi.org/10.3109/17482968.2012.699969

Dupuis, L., Dengler, R., Heneka, M. T., Meyer, T., Zierz, S., Kassubek, J., Fischer, W., Steiner, F., Lindauer, E., Otto, M., Dreyhaupt, J., Grehl, T., Hermann, A., Winkler, A. S., Bogdahn, U., Benecke, R., Schrank, B., Wessig, C., Grosskreutz, J., Ludolph, A. C., … GERP ALS Study Group (2012). A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PloS one, 7(6), e37885. https://doi.org/10.1371/journal.pone.0037885

Lautenschlaeger, J., Prell, T., & Grosskreutz, J. (2012). Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 13(2), 166–177. https://doi.org/10.3109/17482968.2011.641569